BSL3 in vivo & in vitro pre-clinical testing facility

BSL3 in vivo & in vitro pre-clinical testing facility

Contract Research

Information

ERINHA offers a large range of in-vitro and in-vivo research services to the entire scientific community worldwide: This includes but is not limited to: standard virologic assays high throughput antiviral/therapeutic screening assays pre-clinical vaccine testing capacity diagnostic development and testing capacity virus propagation and quantification A large range of animal diseases models small animal (e.g. mice, hamsters) disease models Non-Human Primates (NHP) disease models standard in vivo virologic and immunological assays etc.
ERINHAERINHA (European Research Infrastructure on Highly Pathogenic Agents) is a distributed non-profit infrastructure dedicated to research on high-consequence pathogens. We gather leading European high-containment facilities and national scientific institutes with longstanding experience in infectious disease research. We provide expertise, training, and access to facilities and additional capacities necessary to conduct broad and ambitious projects on highly pathogenic agents, and work with academic, industry and governmental partners to develop new and innovative medical countermeasures. Our services also include expertise and training on biosecurity, biosafety, laboratory operations and management, among other topics.

Log in